CAS 1177261-73-2

Fórmula: C19H24N4O5

InChI: InChI=1S/C19H24N4O5/c1-26-15-10-12-13(11-16(15)27-2)20-19(21-17(12)24)23-7-5-22(6-8-23)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H,20,21,24)

Clave InChI: SOPCVLMNPKFJKQ-UHFFFAOYSA-N

SMILES: COC1=C(C=C2C(=C1)C(=O)NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)OC

Terazosin Related Compound B

CAS: 1177261-73-2

Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi

Fórmula: C₁₉H₂₄N₄O₅

Forma y color: White Powder

Peso molecular: 388.17467

Ref: 45-1643474

Terazosin EP Impurity B

Producto controlado

CAS: 1177261-73-2

Fórmula: C₁₉H₂₄N₄O₅

Forma y color: Neat

Peso molecular: 388.42

Ref: 86-MM0843.02

6,7-Dimethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one

Producto controlado

CAS: 1177261-73-2

Applications 6,7-Dimethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one is an analogue of Terazosin (T105000), an α-1-adrenergicblocker related to prazosin (P702325).
References Patterson, S.E., et al.: J. Chromatog., 311, 206 (1984), Fort, F.L., et al.: Drug Chem. Toxicol., 7, 435 (1984), Lepor, H., et al.: J. Urol., 148, 1467 (1992),

Fórmula: C₁₉H₂₄N₄O₅

Forma y color: Neat

Peso molecular: 388.42

Ref: TR-D471180

Terazosin EP Impurity B

CAS: 1177261-73-2

Fórmula: C₁₉H₂₄N₄O₅

Peso molecular: 388.42

Ref: ST-EA-CP-T17002

6,7-Dimethoxy-2-[4-[(tetrahydro-2-furanyl)carbonyl]-1-piperazinyl]-4(3H)-quinazolinone

CAS: 1177261-73-2

6,7-Dimethoxy-2-[4-[(tetrahydro-2-furanyl)carbonyl]-1-piperazinyl]-4(3H)-quinazolinone is a drug product. It is an analytical standard for the impurity of CAS No. 1177261-73-2. This compound has been synthesized by custom synthesis and its purity is high. The compound has been used in research and development of drugs, pharmacopoeia, HPLC standards, and other related fields.

Fórmula: C₁₉H₂₄N₄O₅

Pureza: Min. 95%

Peso molecular: 388.42 g/mol

Ref: 3D-ID63842